Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: Implications for treatment policy in the region

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Leslie, Toby ^a,b   Moiz, Bushra ^c   Mohammad, Nader ^a   Amanzai, Omar ^a   Ur Rasheed, Haroon ^a   Jan, Sakhi ^a   Siddiqi, Abdul M ^a   Nasir, Amna ^c   Beg, Mohammad A ^c   Vink, Martijn ^a  

^a Department of Research and Development   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Afghanistan; G6PD; Glucose 6 phosphate dehydrogenase deficiency; Malaria; Primaquine; Relapse; Vivax

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CODON; ETHNIC GROUP; FEMALE; GENETIC SCREENING; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; MALARIA; MALARIA CONTROL; MALE; PREVALENCE;

ADOLESCENT; AFGHANISTAN; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA; MALE; PHENOTYPE; PREVALENCE; PRIMAQUINE; URBAN POPULATION; YOUNG ADULT;

EID: 84879809029     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-230     Document Type: Article

References (19)

1. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Beutler E, Duparc S, AmJTrop Med Hyg 2007 77 779 789 (Pubitemid 351844308)
2. G6PD Deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI, PLoS Med 2012 9 1001339 10.1371/journal.pmed.1001339 23152723
3. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siqueira AM, Ferreira LC, Araujo JR, Mourao MP, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, del Portillo H, Ordi J, Alonso PL, Bassat Q, Clin Infect Dis 2012 55 67 74 10.1093/cid/cis615 22772803
4. Glucose-6-phosphate dehydrogenase deficiency. Cappellini MD, Fiorelli G, Lancet 2008 371 64 74 10.1016/S0140-6736(08)60073-2 18177777
5. Enzymatic deficiency in primaquine-sensitive erythrocytes. Alving AS, Carson PE, Flanagan CL, Ickes CE, Science 1956 124 484 485 13360274
6. The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJ, Rowland M, PLoS Med 2010 7 1000283 10.1371/journal.pmed.1000283 20520804
7. Afghanistan Information and Management Systems. http://www.aims.org.af
8. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Beutler E, Mitchell M, Blood 1968 32 816 818 4386875
9. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E, Blood Cells Mol Dis 2012 48 154 165 10.1016/j.bcmd.2012.01.001 22293322
10. Library of Congress: Country Series-Afghanistan. http://lcweb2.loc.gov/ frd/cs/aftoc.html
11. Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes. Bouma MJ, Goris M, Akhtar T, Khan N, Kita E, Trans R Soc Trop Med Hyg 1995 89 62 64 10.1016/0035-9203(95)90661-4 7747310
12. Caroe O, The Pathans: 500BC-AD1957 Oxford: Oxford University Press 1984
13. Frequency of glucose-6-phosphate dehydrogenase deficiency in some ethnic groups of Pakistan. Ali N, Anwar M, Ayyub M, Bhatti FA, Nadeem M, Nadeem A, J Coll Physicians Surg Pak 2005 15 137 141 15808089 (Pubitemid 40575957)
14. Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan. Rebholz CE, Michel AJ, Maselli DA, Saipphudin K, Wyss K, Malar J 2006 5 51 10.1186/1475-2875-5-51 16780577 (Pubitemid 44211708)
15. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. Peters AL, Van Noorden CJ, J Histochem Cytochem 2009 57 1003 1011 10.1369/jhc.2009.953828 19546473
16. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, Taylor WR, Baird JK, Menard D, PLoS One 2011 6 28357 10.1371/journal.pone. 0028357 22164279
17. Pyrethroid-impregnated bed nets for personal protection against malaria for Afghan refugees. Rowland M, Bouma M, Ducornez D, Durrani N, Rozendaal J, Schapira A, Sondorp E, Trans R Soc Trop Med Hyg 1996 90 357 361 10.1016/S0035-9203(96)90505-2 8882175 (Pubitemid 26335954)
18. A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan. Leslie T, Mayan I, Mohammed N, Erasmus P, Kolaczinski J, Whitty CJ, Rowland M, PLoS One 2008 3 2861 10.1371/journal.pone.0002861 18682739
19. Compliance with 14-day primaquine therapy for radical cure of vivax malaria-a randomized placebo-controlled trial comparing unsupervised with supervised treatment. Leslie T, Rab MA, Ahmadzai H, Durrani N, Fayaz M, Kolaczinski J, Rowland M, Trans R Soc Trop Med Hyg 2004 98 168 173 10.1016/S0035-9203(03)00041-5 15024927 (Pubitemid 38949897)